Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03752697 · ClinicalTrials.gov registry record
Metacognition in Neurological Injury
A clinical trial of Brain Injuries, sponsored by University of Nebraska Lincoln.
- Active
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT03752697: Active study of Brain Injuries, sponsored by University of Nebraska Lincoln.
NCT03752697 is a study of Brain Injuries that is active but no longer recruiting, run by University of Nebraska Lincoln. The registered enrollment target is 100 participants, below the 326-participant average among 22 other Brain Injuries trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03752697, a study of Brain Injuries, is active but no longer recruiting, sponsored by University of Nebraska Lincoln.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the trajectory of metacognitive functioning throughout phases of recovery from neurological insult, and to determine its relationship to rehabilitation compliance and functional outcome. It is hypothesized that metacognitive accuracy improves over time, and is a significant predictor of engagement in rehabilitation activities.
Primary Outcome
The computerized metamemory test produces scores that are used to calculate a gamma coefficient, which is a quantitative measure of the individual's metacognitive performance/accuracy.
Conditions Studied
Interventions
- BEHAVIORAL metacognitive performance
Study Locations (1)
Nebraska
- University of Nebraska-Lincoln - Lincoln
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-12-13 |
| Est. Completion | 2026-06 |
What the registry record for NCT03752697 still lists
NCT03752697 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 326-participant average among 22 other Brain Injuries trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Brain Injuries appearing as the primary indexed condition, and to 1 intervention - of which metacognitive performance is the first listed.
NCT03752697 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT03752697 about?
NCT03752697 is a clinical study titled "Metacognition in Neurological Injury". The purpose of this study is to investigate the trajectory of metacognitive functioning throughout phases of recovery from neurological insult, and to determine its relationship to rehabilitation compliance and functional outcome. It is hypothesized that metacognitive accuracy improves over time, an...
What is the current status of trial NCT03752697?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2018-12-13. Estimated completion is 2026-06.
What conditions does trial NCT03752697 study?
This clinical trial studies the following conditions: Brain Injuries.
What interventions are being tested in trial NCT03752697?
The interventions under investigation include: metacognitive performance (BEHAVIORAL).
Who is sponsoring clinical trial NCT03752697?
This trial is sponsored by University of Nebraska Lincoln, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03752697 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03752697's enrollment target sits among peer trials
100 12th of 22 higher than 11 of 22 other Brain Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
RECRUITING · NA
-
The Gut-Brain Axis During Neurorehabilitation; Prebiotic Treatment to Alter the Gut Microbiome and Neurologic Symptoms
RECRUITING · NA
-
Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma
RECRUITING · NA
-
Screening Emotions in Adolescents at the Hospital for mTBI
RECRUITING
-
Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
RECRUITING · NA
-
The HOME Study (Healthy Options Made Easy): Telehealth Nutrition Sessions for People Living With Brain Injury
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI